Philip M Kruyt
Research Subjects
Research Interests
Philip M Kruyt has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Bert van Ramshorst
Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands
1 shared publication - Dirk Jan Gouma
Department of Surgery, Academic Medical Center, Amsterdam, the Netherlands
1 shared publication - Djamila Boerma
Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands
1 shared publication - Ellen Tromp
Department of Epidemiology and Statistics, St Antonius Hospital Nieuwegein, 3435 CM Nieuwegein, The Netherlands
1 shared publication - Grard AP Nieuwenhuijzen
Dept. of Surgery, Catharina Hospital Eindhoven
1 shared publication - Johannes C. Kelder
Department of Cardiology, St. Antonius Hospital, 3435 CM Nieuwegein, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 12 January 2012
- Published by Springer Nature in Trials
- Vol. 13 (1) , 7
Acute cholecystitis in high risk surgical patients: percutaneous cholecystostomy versus laparoscopic cholecystectomy (CHOCOLATE trial): Study protocol for a randomized controlled trial
Background: Laparoscopic cholecystectomy in acute calculous cholecystitis in high risk patients can lead to significant morbidity and mortality. Percutaneous cholecystostomy may be an alternative treatment option but the current literature does not provide the surgical community with evidence based advice. Methods/Design: The CHOCOLATE trial is a randomised controlled, parallel-group, superiority multicenter trial. High risk patients, defined as APACHE-II score 7-14, with acute calculous cholecystitis will be randomised to laparoscopic cholecystectomy or percutaneous cholecystostomy. During a two year period 284 patients will be enrolled from 30 high volume teaching hospitals. The primary endpoint is a composite endpoint of major complications within three months following randomization and need for re-intervention and mortality during the follow-up period of one year. Secondary endpoints include all other complications, duration of hospital admission, difficulty of procedures and total costs. Discussion: The CHOCOLATE trial is designed to provide the surgical community with an evidence based guideline in the treatment of acute calculous cholecystitis in high risk patients. Trial Registration: Netherlands Trial Register (NTR): NTR2666
- 12 January 2012
- Published by Springer Nature in Trials
- Vol. 13 (1) , 7
Open AccessAcute cholecystitis in high risk surgical patients: percutaneous cholecystostomy versus laparoscopic cholecystectomy (CHOCOLATE trial): Study protocol for a randomized controlled trial
Background: Laparoscopic cholecystectomy in acute calculous cholecystitis in high risk patients can lead to significant morbidity and mortality. Percutaneous cholecystostomy may be an alternative treatment option but the current literature does not provide the surgical community with evidence based advice. Methods/Design: The CHOCOLATE trial is a randomised controlled, parallel-group, superiority multicenter trial. High risk patients, defined as APACHE-II score 7-14, with acute calculous cholecystitis will be randomised to laparoscopic cholecystectomy or percutaneous cholecystostomy. During a two year period 284 patients will be enrolled from 30 high volume teaching hospitals. The primary endpoint is a composite endpoint of major complications within three months following randomization and need for re-intervention and mortality during the follow-up period of one year. Secondary endpoints include all other complications, duration of hospital admission, difficulty of procedures and total costs. Discussion: The CHOCOLATE trial is designed to provide the surgical community with an evidence based guideline in the treatment of acute calculous cholecystitis in high risk patients. Trial Registration: Netherlands Trial Register (NTR): NTR2666